EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 63.40
-0.10 (-0.16%)
At close: Dec 22, 2025
EirGenix Market Cap
EirGenix has a market cap or net worth of 19.01 billion as of December 23, 2025. Its market cap has decreased by -31.75% in one year.
Market Cap
19.01B
Enterprise Value
17.52B
Revenue
936.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
63.40
Market Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 19.01B, an increase of 317.07%. That is a compound annual growth rate of 17.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 19.16B | -13.11% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | 9.70B | 108.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 248.14B |
| PharmaEssentia | 182.89B |
| Heron Neutron Medical | 85.13B |
| Lotus Pharmaceutical | 74.42B |
| Bora Pharmaceuticals Co., LTD. | 62.46B |
| Lin BioScience | 33.67B |
| Lumosa Therapeutics | 30.91B |
| Center Laboratories | 28.37B |